« Back

Bill T. Ameredes, PhD
Professor, Division of Pulmonary Critical Care & Sleep Medicine

Bill T. Ameredes, PhD

Bill T. Ameredes, PhD
Division of Pulmonary Critical Care & Sleep Medicine
Department of Internal Medicine
Director, KL2 Scholars Program, Institute for Translational Sciences (ITS)
Director, Inhalation Toxicology Core (ITC) Facility
Director, NIEHS Environmental Toxicology Training Program
UT Distinguished Teaching Professor, Academy of Master Teachers
William C. Levin Chair, Environmental Toxicologyy

University of Texas Medical Branch
Division of Pulmonary, and Critical Care Medicine
Medical Research Building 8.104
301 University Blvd.
Galveston, TX 77555-1083
Phone: 409.772.8104
Fax: 409.772.5841


Degree/Training Completed Year Name & Location
Ph.D. 1989 Ohio State University, Columbus, Ohio
Post-Doctoral Training 1990 University of Florida, Gainesville, FL
Post-Doctoral Fellowship 1992 University of Florida, Gainesville, FL

Research Interests

  • Airway smooth muscle biology and beta-receptor regulation
  • Immune/inflammatory cytokine responses of the airway
  • Beta-agonist regulation of MAPK mechanisms
  • Role of carbon monoxide in airway inflammation
  • Role of nitric oxide in airway inflammation

Selected Publications

  1. Sokol K, Sur S, Ameredes BT. Inhaled environmental allergens and toxicants as determinants of the asthma phenotype. Chapter 4 in: Heterogeneity in Asthma: Translational Profiling and Phenotyping, AR Brasier, ed., Advances in Experimental Medicine and Biology, Vol. 795, 43-74, XIV, 354 p. 33 illus., 25 illus. in color; Springer, New York, NY. E-book ISBN 978-1-4614-8603-9; Hardcover ISBN 978-1-4614-8602-2, 2014.
  2. Terasaki J, Nishi SPE, Ameredes BT, Sharma G. Arformoterol: Rationale for use in chronic obstructive pulmonary disease. Clin. Invest. 4(5), 429–439, 2014
  3. Ruiz, J, Ameredes, BT. The cellular effects of carbon monoxide in the airway. Curr Mol Med   13(1):94-108, 2013.
  4. Devekar, R., Ameredes BT, Calhoun WJ. Symptom-based controller therapy: a new paradigm for asthma treatment. Curr Allergy Asthma Reports Oct;13(5): 427-33. doi: 10.1007/s11882-013-0375-7, 2013.
  5. Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, Cherniack RM, Chinchilli VM, Craig T, Denlinger L, DiMango EA, Engle LL, Fahy JV, Grant JA, Israel E, Jarjour N, Kazani SD, Kraft M, Kunselman SJ, Lazarus SC, Lemanske Jr RF, Lugogo N, Martin RM, Meyers DA, Moore WC, Pascual R, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Boushey HA. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA Sept 12, 308(10): 987-997. 2012.                    
  6. Ameredes, BT. Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle. Frontiers in Bioscience (Schol Ed). 3:643-54, 2011.
  7. Ameredes, BT. Translating airway biomarker information into practice: from theoretical science to applied medicine. Pulm Pharmacol Ther. Sep 30. [Epub ahead of print] 2010.
  8. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med. 8(5): 437-445, 2008.

»Pub Med Search
»Curriculum Vitae

Site Managed by UTMB Information Design Services.